Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Felix, A.
1951.
The preparation, testing and standardization of typhoid vaccine.
Epidemiology and Infection,
Vol. 49,
Issue. 2-3,
p.
268.
Anderson, E. S.
1951.
The significance of Vi-phage types F1 and F2 of Salmonella typhi.
Epidemiology and Infection,
Vol. 49,
Issue. 4,
p.
458.
Felix, A.
1952.
The properties of differentSalmonellaVi antigens.
Epidemiology and Infection,
Vol. 50,
Issue. 4,
p.
515.
Felix, A.
1952.
The Vi antigen ofSalmonella paratyphi A.
Epidemiology and Infection,
Vol. 50,
Issue. 4,
p.
540.
SPAUN, JØRN
1954.
ESTIMATION OF TYPHOID VACCINES BY AGGLUTININ TITRATION OF IMMUNE RABBIT SERA.
Acta Pathologica Microbiologica Scandinavica,
Vol. 34,
Issue. 3,
p.
286.
Chu, David C. Y.
Hoyt, Robert E.
and
Pickett, M. J.
1956.
Solubility of Vi Antigen ofSalmonella Typhi.
Epidemiology and Infection,
Vol. 54,
Issue. 4,
p.
585.
Spaun, J.
1956.
THE INFLUENCE OF STORAGE ON THE ANTIBODY‐STIMULATING PROPERTIES OF DIFFERENT TYPHOID VACCINES.
Acta Pathologica Microbiologica Scandinavica,
Vol. 38,
Issue. 1,
p.
73.
Archer, G. T. L.
and
Whitby, J. L.
1957.
Protection of mice by living Vi and O vaccines against death caused bySalmonella paratyphi C.
Epidemiology and Infection,
Vol. 55,
Issue. 4,
p.
513.
Vella, E. E.
1963.
Chrome typhoid vaccine.
Journal of Hygiene,
Vol. 61,
Issue. 1,
p.
43.
Archer, ‐General G. T. L.
1963.
Miscellaneous Immunizations.
International Journal of Clinical Practice,
Vol. 17,
Issue. 11,
p.
690.
Herrlich, A.
1965.
Handbuch der Schutzimpfungen.
p.
542.
Khan, M Imran
Ochiai, R Leon
and
Clemens, John D
2010.
Population impact of Vi capsular polysaccharide vaccine.
Expert Review of Vaccines,
Vol. 9,
Issue. 5,
p.
485.